Skip to content
Doctor licensed in Poland · licence no. 3211301 Prescription on the EU model Every day, 6am to midnight (Malta time)

Rosuvastatin and Crestor: strengths, side effects and atorvastatin

Rosuvastatin is a statin, taken once a day, that lowers LDL cholesterol and is also used to help prevent a first major cardiovascular event, such as a heart attack or stroke, in people at high risk. This page explains how it works, the 5 to 40 mg strengths, who should not take it, the muscle and liver warnings, the interactions that matter and how it differs from atorvastatin, so that you know what the doctor will look at.

How rosuvastatin lowers cholesterol

Rosuvastatin acts mainly in the liver. It blocks HMG-CoA reductase, the enzyme that controls an early step in making cholesterol, so the liver puts more LDL receptors on its cells and clears more LDL from the blood.

Section 5.1 of the summary of product characteristics (SmPC) for Celmantin 10 mg, a rosuvastatin product authorised in Malta, states that an effect appears within one week, about 90% of the full response is reached in two weeks and the maximum usually by four weeks, after which it is maintained.

What rosuvastatin is authorised for

The SmPC lists two uses. The first is raised cholesterol: primary hypercholesterolaemia, including the inherited heterozygous familial form, and mixed dyslipidaemia, when diet, exercise and weight reduction have not lowered it enough; for the homozygous familial form it is used together with other lipid-lowering treatments, or when these are not appropriate. The second is the prevention of major cardiovascular events in people at high risk of a first event, alongside correction of their other risk factors.

In both cases the tablet is added to a cholesterol-lowering diet. The dose is matched to your cholesterol level, your cardiovascular risk and your response, so two people with a similar result may take different strengths.

Crestor and other rosuvastatin products in Malta

In the Medicines Authority (MMA) register, every authorised rosuvastatin product is classified POM, a prescription-only medicine: 42 single-substance authorisations and 13 combinations, all of them with ezetimibe. Crestor 5 mg, 10 mg and 20 mg hold current authorisations, for example Crestor 10 mg under AA1438/12402; the older MA046 authorisations, including Crestor 40 mg, are recorded as withdrawn.

Generics such as Celmantin and Corvapro Neo are authorised at 5, 10, 20 and 40 mg. A combination product already contains rosuvastatin, so tell the doctor if you take one. The MMA page for Crestor 10 mg (AA1438/12402) carries no SmPC file, so the medical facts here come from the SmPC of Celmantin 10 mg (MA032/08102).

Strengths and doses in the SmPC

Rosuvastatin is used under a doctor's care, and the doctor sets your dose. The table shows what the SmPC says for adults; it is a summary of the product information, not a schedule to follow on your own.

SituationWhat the SmPC says
Starting treatment for raised cholesterol5 mg or 10 mg once a day, whether or not you have taken another statin before
Increasing the doseOne step up after 4 weeks, if needed
The 40 mg strengthOnly for severe hypercholesterolaemia at high cardiovascular risk that is not controlled on 20 mg, with regular follow-up; specialist supervision is recommended when it is started
Preventing cardiovascular eventsThe risk-reduction study used 20 mg a day
Age over 70Starting dose 5 mg
Moderate kidney impairmentStarting dose 5 mg; 40 mg is contraindicated
Severe kidney impairmentContraindicated at every dose
Asian ancestryStarting dose 5 mg; 40 mg is contraindicated
Risk factors for muscle problemsStarting dose 5 mg; 40 mg is contraindicated in some cases
Time of dayAny time, with or without food

What the dose-response study showed

Section 5.1 of the SmPC summarises a dose-response study in people with primary hypercholesterolaemia, with 17 or 18 people at each strength. The table shows the average change in LDL cholesterol in that clinical study. These are group averages, not a forecast for you, and side effects are reported more often at 40 mg.

Daily doseAverage change in LDL cholesterol
Placebo-7%
5 mg-45%
10 mg-52%
20 mg-55%
40 mg-63%

Who should not take rosuvastatin

The SmPC contraindicates rosuvastatin in the following situations; the last point applies to the 40 mg strength only.

  • An allergy to rosuvastatin or to any other ingredient of the tablet.
  • Active liver disease, including unexplained, persistent rises in liver enzymes or a rise above three times the upper limit of normal.
  • Severe kidney impairment (creatinine clearance below 30 ml/min).
  • A muscle disease (myopathy).
  • Treatment with ciclosporin or with sofosbuvir, velpatasvir and voxilaprevir.
  • Pregnancy, breastfeeding, or the possibility of pregnancy without suitable contraception.
  • For 40 mg only: moderate kidney impairment, an underactive thyroid, inherited muscle disorders in you or your family, earlier muscle problems on a statin or fibrate, alcohol misuse, Asian ancestry, use of a fibrate and other situations that raise blood levels of the medicine.

Muscles, liver, skin and blood sugar: the warnings

Muscle pain is a common side effect. Rarely, statins cause myopathy or rhabdomyolysis, a breakdown of muscle tissue that can lead to kidney failure; with rosuvastatin these are reported more often above 20 mg. The package leaflet asks you to stop the tablets and talk to a doctor without delay if unusual muscle aches last longer than expected. A creatine kinase (CK) blood test then helps decide whether treatment can continue.

The SmPC advises caution if you drink large amounts of alcohol or have had liver disease. Severe skin reactions, including Stevens-Johnson syndrome and DRESS, have been reported; after such a reaction rosuvastatin is never restarted.

Statins as a class can raise blood sugar, and in some people already at high risk this reaches the level of diabetes. The SmPC states that the reduction in vascular risk outweighs this and asks for monitoring if, for example, your fasting glucose is 5.6 to 6.9 mmol/L or your BMI is above 30.

Medicines that interact with rosuvastatin

Rosuvastatin is a poor substrate for the cytochrome P450 liver enzymes, but it depends on transport proteins, and medicines that block them raise its level and the risk of muscle damage. Tell the doctor about everything you take.

  • Ciclosporin and the hepatitis C combination sofosbuvir, velpatasvir and voxilaprevir: contraindicated.
  • Protease inhibitors given with ritonavir: dose adjustment or an alternative is needed.
  • Gemfibrozil: not recommended; other fibrates also raise the risk of muscle problems, and 40 mg is contraindicated with a fibrate.
  • Fusidic acid by mouth or injection: rosuvastatin is stopped for the course and restarted seven days after the last dose.
  • Clopidogrel, darolutamide, regorafenib and other medicines expected to at least double rosuvastatin exposure: the SmPC advises starting at 5 mg.
  • Warfarin and other vitamin K antagonists: the INR can rise, so it is monitored.
  • Antacids with aluminium and magnesium hydroxide: taken at the same time they halved rosuvastatin levels; taking the antacid two hours later reduced this.
  • The combined pill: rosuvastatin raised the levels of ethinylestradiol and norgestrel by 26% and 34%.

Side effects by frequency

The SmPC describes the side effects as generally mild and transient; in controlled trials fewer than 4% of people stopped because of them. They tend to increase with the dose.

  • Common (up to 1 in 10 people): headache, dizziness, constipation, nausea, stomach pain, muscle pain, weakness, and diabetes in people already at risk.
  • Uncommon (up to 1 in 100): itching, rash, hives.
  • Rare (up to 1 in 1,000): allergic reactions including angioedema, myopathy, rhabdomyolysis, muscle rupture, a lupus-like syndrome, pancreatitis, raised liver enzymes, a low platelet count.
  • Very rare (fewer than 1 in 10,000): jaundice, hepatitis, joint pain, polyneuropathy, memory loss, blood in the urine, breast enlargement in men.
  • Frequency not known: depression, sleep problems, peripheral neuropathy, cough, shortness of breath, diarrhoea, tendon problems, oedema, myasthenia gravis, severe skin reactions and immune-mediated necrotising myopathy.

Rosuvastatin compared with atorvastatin

Atorvastatin, authorised in Malta under names including Lipitor, is another statin that blocks the same liver enzyme. The table sets side by side what the two SmPCs say; it is not a ranking.

PointRosuvastatin (Celmantin SmPC)Atorvastatin (Lipitor SmPC)
Usual starting dose5 mg or 10 mg once a day10 mg once a day
Highest dose40 mg, for a narrow group80 mg once a day
Dose changesAfter 4 weeks, if neededAt intervals of 4 weeks or more
Handling by the liverPoor substrate for cytochrome P450 enzymesBroken down by CYP3A4, so medicines that block CYP3A4 can raise its level
Grapefruit juiceNot listed among the interactions in the SmPC read for this pageLarge quantities are not recommended
Kidney impairmentLower starting dose if moderate, contraindicated if severeNo dose adjustment required
Time of dayAny time, with or without foodAny time, with or without food

Choosing between the two statins

The doctor chooses between them from your cholesterol result, cardiovascular risk, kidney function and other medicines. More is on our page on Lipitor and on our page on statins and cholesterol medicines.

Pregnancy and breastfeeding

Rosuvastatin is contraindicated in pregnancy and while breastfeeding. Cholesterol and related substances are essential for the development of the baby in the womb, which is why the SmPC rules out treatment in pregnancy. If you could become pregnant, use suitable contraception while you take it; if you become pregnant during treatment, stop the tablets and tell the doctor.

When to see a doctor in person or call 112

For some conditions, and in some individual cases, it is advisable to see a doctor in person; the doctor may recommend this. In an emergency, call 112. The leaflet asks you to stop rosuvastatin and seek medical help, or talk to a doctor, without delay in the situations below.

  • Difficulty breathing, or swelling of the face, lips, tongue or throat: call 112 or go to Accident and Emergency.
  • Red, target-like patches with blisters or skin peeling, or a widespread rash with high temperature and enlarged lymph nodes.
  • Unusual muscle aches that last longer than expected, or a muscle rupture.
  • Signs of a lupus-like syndrome, such as a rash, joint problems and effects on blood cells.

Blood tests before and during treatment

The SmPC recommends liver tests before you start and three months later, and a CK test if muscle symptoms appear; a dose change is judged against your cholesterol result. You have these tests taken through a doctor in Malta or at a laboratory, and the doctor reviewing your request may ask you for recent results. What a lipid profile measures is explained in our guide to high cholesterol.

Your prescription and the pharmacy

If the doctor issues a prescription, you receive it as a PDF by email. You print it and bring it on paper to a pharmacy in Malta together with photo identification. Your prescription is issued in the standard EU cross-border format set out in Directive 2012/52/EU. A pharmacy in Malta may dispense it; the decision rests with the pharmacist.

Take the prescription to a pharmacy within six months of the date on it; a prescription for an antibiotic cannot be dispensed more than ten days after its date of issue.

What does it cost?

The button on this page shows the fee for the doctor's review of your request. We do not sell medicines. It is not an ePrescription and does not appear in myHealth; it is outside POYC and the Government Formulary List, and you pay for the medicine at the pharmacy in full.

Who reviews your request?

Damian Wojno, a doctor registered with the Polish Medical Chamber, licence no. 3211301, reviews your answers to a medical questionnaire about the medicine, your health and other medicines you take. The doctor is not registered with the Medical Council of Malta. If the doctor has questions, they ask them in writing in the chat in your account, and you get an email to let you know. There is no video call, no phone call and no live chat. The doctor may ask for records, test results or a measurement such as blood pressure, may recommend that you see a doctor in Malta, and may decline.

Is rosuvastatin prescription-only in Malta?

Every authorised rosuvastatin product in the Medicines Authority register is classified POM, a prescription-only medicine, including Crestor 5 mg, 10 mg and 20 mg and generics such as Celmantin; the MMA product pages show this per product, for example Crestor 10 mg (AA1438/12402).

What is the difference between rosuvastatin and atorvastatin?

Both are statins that block the same liver enzyme. Their SmPCs differ in the dose range (up to 40 mg and up to 80 mg), in how the liver handles them (atorvastatin through CYP3A4) and in the advice for kidney impairment. Which one suits you is the doctor's decision.

Can I take rosuvastatin in the evening?

The SmPC allows rosuvastatin at any time of day, with or without food, so evening is possible; what matters more is taking it every day.

What should I do if my muscles ache on rosuvastatin?

The package leaflet asks you to stop the tablets and talk to a doctor without delay if unusual muscle aches last longer than expected. A CK blood test helps the doctor decide whether you continue, change the dose or change medicine.

Can a pharmacy in Malta dispense a prescription from a doctor in another EU country?

A prescription from a doctor in another EU country can be dispensed in Malta (Article 81(3) of the Medicines Act, Cap. 458) if the pharmacist can confirm the doctor's licence. The decision rests with the pharmacist, who may refuse.